Showing results (1761-1770 of 3,475) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|July 18, 2019
A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaJulie M Janssen, T P C Dorlo, D Niewerth, et al.Clinical Pharmacokinetics|July 20, 2019
Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in Patients with Chronic Obstructive Pulmonary DiseaseRashmi Mehta, Colm Farrell, Siobhán Hayes, et al.Clinical Pharmacokinetics|April 22, 2024
Development of a Weight-Band Dosing Approach for Vosoritide in Children with Achondroplasia Using a Population Pharmacokinetic ModelYulan Qi, Ming Liang Chan, Diane R Mould, et al.Clinical Pharmacokinetics|August 14, 2014
Pharmacokinetic evaluations of the co-administrations of vandetanib and metformin, digoxin, midazolam, omeprazole or ranitidineSusanne Johansson, Jessica Read, Stuart Oliver, et al.Clinical Pharmacokinetics|August 14, 2014
Vancomycin pharmacokinetic and pharmacodynamic models for critically ill patients with post-sternotomy mediastinitisOlivier Mangin, Saïk Urien, Jean-Luc Mainardi, et al.Clinical Pharmacokinetics|July 1, 1989
Bayesian forecasting of serum lithium concentrations. Comparison with traditional methodsP J Williams, J L Browne, R A PatelClinical Pharmacokinetics|June 29, 2016
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly IndividualsJan-Frederik Schlender, Michaela Meyer, Kirstin Thelen, et al.Clinical Pharmacokinetics|February 1, 1989
Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failureJ P Mulrow, M H CrawfordClinical Pharmacokinetics|October 17, 2013
Pharmacokinetics and toxicity of intrathecal liposomal cytarabine in children and adolescents following age-adapted dosingAndreas Peyrl, Robert Sauermann, Monika Chocholous, et al.Pageof 348